MOTS-C

MOTS-C is a naturally occurring peptide being studied in metabolism and exercise biology. Early findings are interesting, but do not establish a benefit from taking a consumer product.

Early researchResearch added: 29 October 2026

Check the identity first.

MOTS-C is a specific research peptide, but a label alone does not verify its contents.

Why the interest?

MOTS-C is often discussed in connection with energy, metabolism and exercise.

Energy and exercise

Claims you may come across

Reported benefits, not product promises

Support for metabolic health.
Better exercise capacity and recovery.

Personal stories are anecdotal. They cannot show whether a product caused a change, how often it happens or what the risks are.

How much is backed up?

These ideas mainly come from laboratory and animal work, plus studies measuring the body's own MOTS-C after exercise. They do not show that taking a product provides those benefits.

Research context: Lee et al. (2015): MOTS-c promotes metabolic homeostasis

MOTS-C & exercise

MOTS-C is a mitochondrial-derived peptide studied in metabolism and exercise biology. The two studies below examine metabolic pathways in cells and mice, and changes in the body’s own MOTS-C after exercise in people.

2015: a signal in metabolic research

In laboratory experiments, MOTS-C activated AMPK, a pathway that helps cells respond to their energy needs. In male mice on a high-fat diet, MOTS-C treatment was associated with less weight gain and better insulin sensitivity. This is a biological mechanism and animal finding, not evidence of a clinical effect in people.

Lee et al., Cell Metabolism (2015): The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance

2021: exercise increased participants’ own MOTS-C

A study of 10 sedentary healthy young men found that a cycle-exercise session increased endogenous MOTS-C in skeletal muscle 11.9-fold. Circulating MOTS-C rose 1.6-fold during exercise and 1.5-fold afterwards, returning to baseline after four hours’ rest. It measured a response to exercise, not a benefit from an external product.

Reynolds et al., Nature Communications (2021): MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

What this tells us

Exercise changed the amount of MOTS-C already in participants’ bodies. That is interesting biology, but it does not tell us whether taking extra MOTS-C would help, or whether a product is safe.

What’s being studied?

Metabolic signallingExercise biology

Research topics are not a promise of benefits.

What we know

Human research includes measuring MOTS-C in muscle and blood. That does not establish a treatment benefit from taking it.

What we don’t know

There is no verified basis here for a consumer product’s identity, purity, dose or clinical benefit.

Risks worth understanding.

Unknown effects from externally administered MOTS-C
Unverified ingredients or strength
Contamination or non-sterility in injectable products

This is not a complete list of risks or a personal safety assessment.

Already have a product?

Keep its packaging and ingredient information. Check the formulation, instructions and supplies together. An unidentified product cannot be made safe by an online dose calculation.

Before mixing: checks & supplies

Context matters.

Medsafe warns that unapproved peptide products outside the regulated medicines system are illegal and potentially harmful.

“Research purposes only” is not a legal exemption or a safety guarantee. This guide is for research and educational purposes only and does not recommend taking this substance.

Read Medsafe’s warning

Common questions

The things you might be wondering.

What is MOTS-C?

It is a peptide produced from mitochondrial DNA and studied in metabolic biology.

Does human research prove a benefit?

No. Human measurement and early research are not proof that a product improves health or performance.

Is there a safe dose I can use?

There is no universal safe dose. Do not use an unverified product; discuss any treatment with a clinician and a confirmed regulated product.

Read it at the source.

Keep the conversation going

Two perspectives on the wider peptide conversation. These episodes provide context; they do not identify or validate a product with this label. Pick a thumbnail to watch here.

Huberman Lab · 7 October 2024

Peptide & Hormone Therapies with Dr Craig Koniver

Andrew Huberman and Dr Craig Koniver talk through peptides, hormone therapies and the interest in them for health and performance. The conversation covers GLP-1 medicines, BPC-157 and growth-hormone-related peptides, along with sourcing and safety. Use it to get familiar with the conversation, then check the studies in our guides before drawing conclusions.

Play loads the YouTube player. Podcast discussion is context, not medical advice.

Episode & transcript

Huberman Lab · 1 June 2026

Peptide Science & Safety with Dr Abud Bakri

Why are peptides getting so much attention? Dr Abud Bakri joins Andrew Huberman to discuss BPC-157, GHK-Cu, melanotan and GLP-1 medicines. They explore what is being studied, why product sourcing matters and where animal findings still need to be tested in humans.